Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

We recently compiled a list of the 7 Blue Chip Stocks with Low PE Ratios. In this article, we are going to take a look at ...

We recently compiled a list of 10 Most Promising Long-Term Stocks According to Hedge Funds. In this article, we will look at ...

Clesrovimab scored on several endpoints, showing an ability to protect infants against the virus in their first RSV season.

Merck & Co.’s Keytruda and Bristol Myers Squibb’s Opdivo are also approved for second-line esophageal cancer. Both Keytruda and Tevimbra can be given at 200 mg via intravenous infusion once ...

The ’60s-era variation gets its anachronistic moniker from a tiny detail on its dial: the spikes on the Rolex crown logo (real name ... by The Burford Dial Company, which was a British Ministry ...

The Dow Jones Industrial Average is down Thursday afternoon with shares of Merck and Intel seeing the biggest declines for the price-weighted average. Supported by world-class markets data from ...

Across the recent three months, 8 analysts have shared their insights on Merck & Co MRK, expressing a variety of opinions spanning from bullish to bearish. The following table summarizes their ...

Please verify your email address. Your browser does not support the video tag. Co-op has been a staple of gaming for most of the medium's lifespan, although its ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other undervalued wide moat stocks. The US economy was able to pass its first soft-landing ...

After several years of mixed results, Merck's R&D productivity is improving as the company shifts more toward areas of unmet medical need. Owing to side effects or lack of compelling efficacy ...